Navigation Links
Cepheid Reports Fourth Quarter and Full Year 2010 Results
Date:1/27/2011

ections (HAIs); the company's ability to successfully introduce and sell products in clinical markets other than HAIs; the rate of environmental biothreat testing conducted by the USPS, which will affect the amount of consumable products sold to the USPS; unforeseen development and manufacturing problems; the potential need for additional intellectual property licenses for tests and other products and the terms of such licenses; lengthy sales cycles in certain markets; the company's reliance on distributors in some regions to market, sell and support its products; the occurrence of unforeseen expenditures, acquisitions or other transactions; the impact of competitive products and pricing; the company's ability to manage geographically-dispersed operations; and underlying market conditions worldwide.  Readers should also refer to the section entitled "Risk Factors" in Cepheid's Annual Report on Form 10-K, its most recent Quarterly Report on Form 10-Q, and its other reports filed with the Securities and Exchange Commission.

All forward-looking statements and reasons why results might differ included in this release are made as of the date of this press release, based on information currently available to Cepheid, and Cepheid assumes no obligation to update any such forward-looking statement or reasons why results might differ.

FINANCIAL TABLES FOLLOWCEPHEIDCONDENSED CONSOLIDATED UNAUDITED STATEMENTS OF OPERATIONS(in thousands, except per share data)Three Months Ended
December 31,Year Ended
December 31,2010200920102009Revenues:System sales

$   13,200$   15,545$   46,416$
42,993Reagent and disposable sales

42,96932,694160,460122,192Total product sales

56,16948,239206,876165,185Other revenues

2,5579655,5925,442Total revenues

58,72649,204212,468170,627Costs and operating expenses:Cost of product sales

26,57027,837105,13595,542Collaboration profit sharing

1,0
'/>"/>

SOURCE Cepheid
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine technology :

1. Cepheid Announces Termination of Contract With the Centers for Disease Control and Prevention to Develop Rapid Point of Care Test for Avian Influenza
2. Cepheid Launches New GeneXpert(R) Tests in Europe for Simultaneous, Rapid Detection of Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus
3. Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of Start Clean Strategy
4. Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection
5. Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized Moderate Complexity by FDA
6. Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin
7. Cepheid Receives Grant to Develop Ten-Color Real-Time PCR Detection Technology for Use in the GeneXpert(R) System
8. Cepheid Reports 2009 Third Quarter Results
9. Cepheid to Webcast Upcoming Financial Presentations
10. Cepheid Collaborates With Pharmaceutical Leader on Chronic Myelogenous Leukemia
11. Cepheid to Webcast Upcoming Financial Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... Pharmaceutical Research and Manufacturers of America,s (PhRMA) ... in the research and development (R&D) of new innovative ... all biopharmaceutical R&D spending – both public and private ... The new R&D numbers, the result of a recent ... newly released PhRMA 2015 Biopharmaceutical Research Industry ...
(Date:4/20/2015)... -- U.S. pharmacy cost increases for active employees and pre- and ... by 2016, according to an analysis by Aon Hewitt ... Aon plc (NYSE: AON ). Pharmacy cost ... percent in 2015 and will continue to rise to 10 ... rate of increase in 2017, with pharmacy costs rising by ...
(Date:4/20/2015)... 20, 2015  Halozyme Therapeutics, Inc. (NASDAQ: ... and drug-delivery therapies, today shared highlights of new ... Cancer Research (AACR) annual meeting. Halozyme also announced ... Phase 2 study in pancreatic cancer, Study 202, ... American Society of Clinical Oncology (ASCO). ...
Breaking Medicine Technology:PhRMA Member Companies Invested $51.2 Billion in R&D in 2014 2PhRMA Member Companies Invested $51.2 Billion in R&D in 2014 3Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 2Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 3Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 4Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 2Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 3Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 4Halozyme Presents New Preclinical Data At The American Association for Cancer Research Annual Meeting, Announces Clinical Data Presentation At ASCO 5
... AMSTERDAM, July 12, 2011 Leading events organiser UBM ... announced that its pharmaceutical ingredients event, CPhI China 2011 and ... China for pharmaceutical machinery and equipment and BioPh China to ... 23rd at the SNIEC in Shanghai, experienced a 36% increase ...
... 12, 2011 Roche (SIX: RO, ROG; OTCQX: ... CALP ) today announced a co-marketing agreement ... for the NimbleGen SeqCap EZ Library solution-based capture ... aims to simplify high throughput targeted resequencing workflows ...
Cached Medicine Technology:China Pharma Events Attract Over 27,000 Visitors 2China Pharma Events Attract Over 27,000 Visitors 3Roche NimbleGen and Caliper Collaborate to Offer Automated Target Enrichment Pipeline Solution for Next-Generation Sequencing 2Roche NimbleGen and Caliper Collaborate to Offer Automated Target Enrichment Pipeline Solution for Next-Generation Sequencing 3
(Date:4/21/2015)... CA (PRWEB) April 21, 2015 The ... at the beautiful Governor’s Academy prep school in Byfield, ... July 10-12, 2015, for boys entering grades 6-12. , ... and supplement the players’ fall coaching. , ... athletes. Not only are these the most unsung positions ...
(Date:4/21/2015)... The Science Museum of Virginia welcomes theoretical ... its Lunch Break Science program. On Wednesday, April 29, Dr. ... guests from the subatomic world of quantum mechanics to astronomical ... members of the community to grab lunch and take a ... will delve into the nucleus and dissect the complex world ...
(Date:4/21/2015)... Hills, CA (PRWEB) April 21, 2015 Dr. ... has just released an interesting infographic that takes a close ... millennials. , The new infographic, which appears on both Dr. ... The Rise of Plastic Surgery in the Age of the ... surgery in Beverly Hills to a variety of A-list ...
(Date:4/21/2015)... (PRWEB) April 21, 2015 Renewable energy, ... a few of the Earth Day topics USM ... and national leaders debate the affect of climate change ... variety of subject matter touching on the environmental concerns ... segments will delve into sustainable lifestyles, clean air options, ...
(Date:4/21/2015)... Freeslate, Inc ., the leading provider ... that the Centre for Catalysis Research and Innovation ... a Freeslate Core Module 3 (CM3) Reaction Screening ... to accelerate current research programs. The systems will be ... be available to academic users and industrial collaborators/ partners ...
Breaking Medicine News(10 mins):Health News:US Sports Camps and The Northeast Football Clinic Announce 2015 Lineman/Linebacker Clinic Schedule 2Health News:Quarks and Forks at the Science Museum of Virginia 2Health News:Beverly Hills Plastic Surgery Expert Dr. Zain Kadri Releases Thought-Provoking New Infographic 2Health News:USM Studios’ Programming Focuses on the Environment 2Health News:University of Ottawa Selects Freeslate Reaction Screening System to Support High-Throughput Research at the Centre for Catalysis Research and Innovation 2Health News:University of Ottawa Selects Freeslate Reaction Screening System to Support High-Throughput Research at the Centre for Catalysis Research and Innovation 3
... , , , ... (Nasdaq: HTWR ) (ASX: HIN) announced today the completion ... stock in a private placement in the United States and Australia ... a purchase price of US$22.00 per share resulting in gross proceeds ...
... pose dangers, experts say , MONDAY, Aug. 17 (HealthDay News) ... amounts of indoor ozone, then "spit" it out in the ... lungs, new research suggests. , "They are saying that compounds ... irritation to the skin," explained one expert, Rajat Sethi, an ...
... two disorders , MONDAY, Aug. 17 (HealthDay News) -- Dr. ... commonly used to combat high blood pressure can help prevent ... But people in the know tend to listen carefully to ... University, because one of his ideas was crucial in the ...
... BEDFORD, Mass., Aug. 17 Insulet Corporation (Nasdaq: ... its OmniPod(R) Insulin Management System, today announced the appointment of ... created role, Mr. Devlin will lead the Company,s Sales and ... , "Peter brings a distinguished track record ...
... interaction, researchers prevent disease production , MONDAY, Aug. ... to block HIV infections in the lab with synthetic ... , In the study, researchers developed synthetic molecules that ... called gp41 to interact with proteins in host cells. ...
... monitored in those with head and neck malignancies, researchers ... levels of post-treatment pain in head and neck cancer ... U.S. researchers have found. , Their study included 339 ... of life at diagnosis and three, six, nine and ...
Cached Medicine News:Health News:HeartWare International, Inc. Closes US$60 Million Financing 2Health News:HeartWare International, Inc. Closes US$60 Million Financing 3Health News:Toxins May Form When Skin, Indoor Ozone Meet 2Health News:Toxins May Form When Skin, Indoor Ozone Meet 3Health News:Blood Pressure Drug Might Work Against MS 2Health News:Blood Pressure Drug Might Work Against MS 3Health News:Insulet Appoints Peter J. Devlin as Chief Commercial Officer 2Health News:Synthetic Protein Thwarts HIV Infection in Lab 2Health News:Pain Level May Predict Survival in Certain Cancer Patients 2
Inquire...
20L...
... The new Finnpipette Focus from ... to combine ergonomics with uncompromising ... handle plate offers a custom ... The new shorter tip cones ...
... A fixed pipette is ideal ... single volume. Fixed volume FInnpipettes ... advantages as other Finnpipette Digital ... Super blow-out (1-40ul), Soft-touch tip ...
Medicine Products: